The Hemorrhagic Complications of Open-Heart Surgery

References

• Roche J. K., Stengle J. M. Open-heart surgery and the demand for blood. JAMA 1973; 225(12)1516
   Google Scholar
• Bayrd E. D. Hematologic complications of cardiac surgery. Adv. Intern. Med. 1974; 19: 57
   Google Scholar
• Barkhan P. Haematologic consequences of major surgery. Br. J. Haematol. 1969; 17: 221
   Google Scholar
• Wisch N., Litwak R. S., Luckban S. B., Glass J. S. Hematologic complication of open-heart surgery. Am. J. Cardiol. 1973; 31: 282
   Google Scholar
• Williams W. J., Bentler E., Erslev A. J., Rundles R. W. Hematology. McGraw-Hill, New York 1972; 138–144–149–155, chap. 122
   Google Scholar
• Gilbert J. W., Bronson W. R., Brecher G. Incidence of bleeding in cardiac surgery with extracorporeal circulation. Ann. N.Y. Acad. Sci. 1964; 115: 302
   Google Scholar
• Hartmann R. C. Hemorrhagic disorder occurring in patients with cyanotic congenital heart disease. Bull. Johns Hopkins Hosp. 1952; 91: 49
   Google Scholar
• Jackson D. P. Hemorrhagic diathesis in patients with congenital cyanotic heart disease: Preoperative management. Ann. N.Y. Acad. Sci. 1964; 115: 235
   Google Scholar
• Gomes M. M. R., McGoon D. C. Bleeding patterns after open-heart surgery. J. Thorac. Cardiovasc. Surg. 1970; 60: 87
   PubMed Web of Science ®Google Scholar
• Kevy S. V., Glickman R. M., Bernhard W. F., Diamond L. K., Gross R. E. The pathogenesis and control of the hemorrhagic defect in open-heart surgery. Surg. Gynecol. Obstet. 1966; 123: 313
   PubMedGoogle Scholar
• Ratnoff O. D. The biology and pathology of initial stages of blood coagulation. Progress in Hematology, E. B. Brown, C. V. Moore. Green & Stratton, New York 1966; Vol. 5: 204
   Google Scholar
• Mustard J. F., Packham M. A. Factors influencing platelet function: Adhesion, release, and aggregation. Pharmacol. Rev. 1970; 22: 97
   PubMed Web of Science ®Google Scholar
• Day H. J., Holmsen H. Concepts of blood platelet release reaction. Ser. Haematol. 1971; 4(1)3
   Google Scholar
• Holmsen H. The platelet: Its membrane, physiology and biochemistry. Clin. Haematol. 1972; 1: 235
   Google Scholar
• de Jong J. C. F., Sibinga T. S., Wildevuur R. H. Thrombocytopenia in extracorporeal circulation (ECC). II. Bubble oxygenator versus artificial kidney. Trans. Am. Soc. Artif Intern. Organs 1975; 21: 40
   Google Scholar
• Moffitt E. A., White R. D., Molnar G. D., McGoon D. C. Comparative effects of whole blood, hemodilution and clear primary solutions on myocardial and body metabolism in man. Can. J. Surg. 1971; 14: 382
   Google Scholar
• Cooley D. A., Beall A. C., Grondin P. Open-heart operations with disposable oxygenators, 5% dextrose prime and normothermia. Surgery 1962; 52: 713
   PubMed Web of Science ®Google Scholar
• Garcia J. B., Pakrashi B. C., Mary D. A., Tandon R. K., Ionescu M. I. Postoperative blood Loss after extracorporeal circulation for heart valve surgery. J. Thorac. Cardiovasc. Surg. 1973; 65: 487
   Google Scholar
• Hellström G., Björk V. O. Hemodilution with rheomacrodex during total body perfusion. J. Thorac. Cardiovasc. Surg. 1963; 45: 395
   PubMedGoogle Scholar
• Raison J. C. A. Clinical report of the use of low-molecular-weight dextran in a rotating oxygenator. Thorax 1962; 17: 338
   PubMedGoogle Scholar
• Gibbon J. H., Camishion R. Problems in hemostasis with extracorporeal apparatus. Ann. N.Y. Acad. Sci. 1964; 115: 195
   Google Scholar
• Gollub S. Some variables affecting hemostasis in cardiopulmonary bypass. Ann. N.Y. Acad. Sci. 1964; 115: 278
   Google Scholar
• Gans H., Siegal D. L., Lillehei C. W., Krivit W. Problems in hemostasis during open-heart surgery. II. On the hypercoagulability of blood during cardiac bypass. Ann. Surg. 1962; 156: 19
   Google Scholar
• Gralnick H. R., Fischer R. D. The hemostatic response to open-heart operations. J. Thorac. Cardiovasc. Surg. 1971; 61: 909
   PubMedGoogle Scholar
• Bachmann F., McKenna R., Cole E. R., Najafi H. The hemostatic mechanism after open-heart surgery. J. Thorac. Cardiovasc. Surg. 1975; 70: 76
   PubMed Web of Science ®Google Scholar
• Mattox K. L., Guinn G. A., Rubio P. A., Beall A. C. Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations. Ann. Thorac. Surg. 1975; 19: 634
   PubMed Web of Science ®Google Scholar
• Signori E. S., Penner J. A., Kahn D. R. Coagulation defects and bleeding in open-heart surgery. Ann. Thorac. Surg. 1969; 8: 521
   PubMedGoogle Scholar
• Hyun B. H., Pence R. E., Davila J., Butcher J., Custer R. P. Heparin rebound phenomenon in extracorporeal circulation. Surg. Gynecol. Obstet. 1962; 115: 191
   Google Scholar
• Gollub S. Heparin rebound in open-heart surgery. Surg. Gynecol. Obstet. 1967; 124: 337
   PubMedGoogle Scholar
• Brögli H. Der Meachanismus des Sogenannten “Heparin-Rebound” nach extrakorporellen Kreislauf. Thromb. Diath. Haemorrh. 1965; 13: 401
   Google Scholar
• Frick P. G., Brögli H. The mechanism of heparin rebound after extracorporeal circulation for open cardiac surgery. Surgery 1966; 59: 721
   PubMedGoogle Scholar
• Casteneda A. R. Must heparin be neutralized following open-heart operations?. J. Thorac. Cardiovasc. Surg. 1966; 52: 716
   Google Scholar
• Gans H., Castaneda A. R. Problems in hemostasis during open-heart surgery. VII. Change in fibrinogen concentration duing and after cardiopulmonary bypass with particular reference to the effect of heparin neutralization on fibrinogen. Ann. Surg. 1967; 165: 551
   PubMedGoogle Scholar
• Estes J. W. Kinetics of anticoagulant effect of heparin. JAMA 1970; 212: 1492
   Google Scholar
• Egerton W. S., Robinson C. L. N. The antiheparin-anticoagulant and hypotensive properties of hexadimethrine and protamine. Lancet 1961; 2: 635
   Google Scholar
• Gourin A., Streisand R. L., Greineder J. K., Stuckey J. H. Protamine sulfate administration and the cardiovascular system. J. Thorac. Cardiovasc. Surg. 1971; 62: 193
   PubMed Web of Science ®Google Scholar
• Goldman B. S., Joison J., Austen W. G. Cardiovascular effects of protamine sulfate. Ann. Thorac. Surg. 1969; 7: 459
   PubMedGoogle Scholar
• Godal H. C., Gjengedal G. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest. Scand. J. Haematol. 1971; 8: 194
   Google Scholar
• Woods J. E., Kirklin J. W., Owen C. A., Thompson J. H., Taswell H. F. Effect of bypass surgery on coagulation-sensitive clotting factors. Mayo Clin. Proc. 1967; 42: 724
   Google Scholar
• Baille Y., Jaquenoud P., Monties J. R., Goudard A., Blinc T., Gouty H., Henry E. La reduction de saigrement postopératoue en chiurgie cardiaque par l'héparinothérapie précoce (quatre-vingtonze observit). Probl. Actuels Réanimation 1968; 5: 1061
   Google Scholar
• Mattox K. L., Guinn G. A., Rubio P. A., Beall A. C. Use of the activated coagulation time in intraoperative heparin reversal for cardiopulmonary operations. Ann. Thorac. Surg. 1975; 19: 634
   PubMed Web of Science ®Google Scholar
• Penner J. A. Experience with a thrombin clotting time assay for measuring heparin activity. Am. J. Pathol. 1974; 61: 645
   Google Scholar
• Weiss H. J. Platelet physiology and abnormal platelet function. N. Engl. J. Med. 1975; 293: 531
   PubMed Web of Science ®Google Scholar
• Weiss H. J. Platelet physiology and abnormal platelet function. N. Engl. J. Med. 1975; 293: 580
   PubMedGoogle Scholar
• Parker-Williams E. J. Platelets in prothesis and pumps. Clin. Haematol. 1972; 1: 413
   Google Scholar
• McKenna R., Bachmann F., Whittaker B., Gilsen J., Weinberg M. The hemostatic mechanism after open-heart surgery. J. Thorac. Cardiovasc. Surg. 1975; 70: 298
   PubMedGoogle Scholar
• Solis R. T., Kennedy P. S., Beall A. C., Noon G. P., DeBakey M. E. Cardiopulmonary bypass-microembolization and platelet aggregation. Circulation 1975; 52: 103
   PubMed Web of Science ®Google Scholar
• Mielke C. H., de Leval M., Hill J. D., Macur M. F., Gerbode F. Drug influence on platelet loss during extracorporeal circulation. J. Thorac. Cardiovasc. Surg. 1973; 66: 845
   PubMedGoogle Scholar
• Solis R. T., Noon G. P., Beall A. C., DeBakey M. E. Particulate microembolism during cardiac operation. Ann. Thorac. Surg. 1974; 17: 332
   PubMedGoogle Scholar
• Gans H., Krivit W. Problems in hemostasis during open-heart surgery. IV. On the changes in the blood clotting mechanism during cardiopulmonary bypass procedures. Ann. Surg. 1962; 155: 353
   PubMed Web of Science ®Google Scholar
• Pike O. M., Marquiss J. E., Breckenridge R. T. A study of platelet counts during cardiopulmonary bypass. Transfusion (Philadelphia) 1972; 12: 119
   PubMedGoogle Scholar
• Harding S. A., Shakoor M. A., Grindon A. J. Platelet support for cardiopulmonary bypass surgery. J. Thorac. Cardiovasc. Surg. 1975; 70: 350
   Google Scholar
• Spragg R. G., Hill R. N., Wedel M. K., Masterson A., Moser K. M. Platelet kinetics in venovenous membrane oxygenation. Trans. Am. Soc. Artif. Intern. Organs 1975; 21: 171
   Google Scholar
• Porter J. M., Silver D., Sabiston D. C. Alterations in fibrinolysis and coagulation associated with cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 1968; 56: 869
   Google Scholar
• Woods J. E., Taswell H. F., Kirklen S. W., Owen C. A. The transfusion of platelet concentrates in patients undergoing heart surgery. Mayo Clin. Proc. 1967; 42: 318
   Google Scholar
• Tamari Y., Aledort L., Puszkin E., Degnan T., Wagner N., Kaplitt M., Pierce E. C. Functional changes in platelets during extracorporeal circulation. Ann. Thorac. Surg. 1975; 19: 639
   Google Scholar
• Salzman E. W. Blood platelet and extracorporeal circulation. Transfusion (Philadelphia) 1963; 3: 274
   PubMed Web of Science ®Google Scholar
• Curry C. A., Cole E., Bachmann F. Appearance of a circulating blood coagulation inhibitor in patients undergoing open-heart surgery. Clin. Res. 1974; 22(Abstr.)249A
   Google Scholar
• Midell A. I., Hallman G. L., Bloodwell R. D., Beall A. C., Yashar J. J., Cooley D. A. Epsilon aminocaproic acid for bleeding after cardiopulmonary bypass. Ann. Thorac. Surg. 1971; 11: 577
   PubMedGoogle Scholar
• Moriau M., Rodhain J., Noel H., DeBeys-Col C., Masure R. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin, and acetyl salicylic acid on the experimental disseminated intravascular coagulation induced by thrombin. Thromb. Diath. Haemorrh. 1974; 32: 171
   Google Scholar
• Fletcher A. P., Akjaersig N., Sherry S. Fibrinolytic mechanisms and the development of thrombolytic therapy. Am. J. Med. 1962; 33: 738
   Google Scholar
• Naeye R. L. Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood 1962; 19: 694
   PubMed Web of Science ®Google Scholar